Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc.verified

ONTX

Price:

$0.9953

Market Cap:

$20.90M

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with PD-1 inhibitor, which is in Phase I/IIa for the treatment of progressive K-Ras mutated non-small cell lung cancer. The company develops a Phase Ib/II ISS with rigosertib monotherapy in patients with advanced squamous cell carcinoma associated with rec...[Read more]

Industry

Biotechnology

IPO Date

2013-07-25

Stock Exchange

NASDAQ

Ticker

ONTX

The Enterprise Value as of October 2024 (TTM) for Onconova Therapeutics, Inc. (ONTX) is 4.51M

According to Onconova Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.51M. This represents a change of -214.34% compared to the average of -3948408.12 of the last 4 quarters.

Onconova Therapeutics, Inc. (ONTX) Historical Enterprise Value (quarterly & annually)

How has ONTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Onconova Therapeutics, Inc. over the last ten years is 2.61M. The current 4.51M Enterprise Value has changed 17.22% with respect to the historical average. Over the past ten years (40 quarters), ONTX's Enterprise Value was at its highest in in the March 2021 quarter at 171.24M. The Enterprise Value was at its lowest in in the December 2022 quarter at -25155105.20.

Quarterly (TTM)
Annual

Average

2.61M

Median

-4970710.00

Minimum

-25166647.25

Maximum

62.77M

Onconova Therapeutics, Inc. (ONTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Onconova Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 261.86%

Maximum Annual Enterprise Value = 62.77M

Minimum Annual Increase = -659.22%

Minimum Annual Enterprise Value = -25166647.25

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-5171703.75-79.45%
2022-25166647.25107.17%
2021-12147895.10-119.35%
202062.77M-463.69%
2019-17259899.50261.86%
2018-4769716.25-150.33%
20179.48M-183.48%
2016-11352015.25-659.22%
20152.03M-92.66%
201427.65M-55.11%

Onconova Therapeutics, Inc. (ONTX) Average Enterprise Value

How has ONTX Enterprise Value performed in the past?

The current Enterprise Value of Onconova Therapeutics, Inc. (ONTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-14162082.03

5-year avg

605.14K

10-year avg

2.61M

Onconova Therapeutics, Inc. (ONTX) Enterprise Value vs. Peers

How is ONTX’s Enterprise Value compared to its peers?

Onconova Therapeutics, Inc.’s Enterprise Value is less than Jaguar Health, Inc. (27.80M), less than iBio, Inc. (15.20M), less than GeoVax Labs, Inc. (14.27M), less than Ocugen, Inc. (263.57M), less than Tonix Pharmaceuticals Holding Corp. (24.26M), greater than Sonnet BioTherapeutics Holdings, Inc. (-468711.00), greater than Palisade Bio, Inc. (-7114049.00), greater than Adial Pharmaceuticals, Inc. (3.12M), greater than Diffusion Pharmaceuticals Inc. (-1447403.00), greater than Aeterna Zentaris Inc. (-11767918.00), greater than Pulmatrix, Inc. (-6252283.00), less than Catalyst Biosciences, Inc. (19.42M), greater than Bio-Path Holdings, Inc. (-381797.00), greater than Moleculin Biotech, Inc. (-3486128.00), less than Vaxart, Inc. (147.63M), less than VBI Vaccines Inc. (39.99M),

Build a custom stock screener for Onconova Therapeutics, Inc. (ONTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Onconova Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Onconova Therapeutics, Inc. (ONTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Onconova Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Onconova Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Onconova Therapeutics, Inc. (ONTX)?

What is the 3-year average Enterprise Value for Onconova Therapeutics, Inc. (ONTX)?

What is the 5-year average Enterprise Value for Onconova Therapeutics, Inc. (ONTX)?

How does the current Enterprise Value for Onconova Therapeutics, Inc. (ONTX) compare to its historical average?